Drug Trial Radar · NCT02452866
Open-Label Study to Evaluate Safety of A Single Dose of SYM-1219
Last checked: Nov 20, 2026Latest source record: Apr 13, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
325
Actual
Start
Jun 2015
Primary completion
Oct 2015
Study completion Oct 2015
Sponsor
- Lead sponsor
- Symbiomix TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- May 25, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Female only, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 3, multi-center, prospective, open-label study to evaluate the safety of SYM-1219 granules containing 2 grams of secnidazole in women and postmenarchal adolescent girls with bacterial vaginosis.
Conditions
- Bacterial Vaginosis
Interventions
SYM-1219Drug
Administered with 4 ounces of unsweetened applesauce, and 8 ounces of water
Primary outcomes
What the sponsor says the trial is designed to measure.
- Numbers of Participants With Treatment Emergent Adverse Events and Laboratory AbnormalitiesTime frame: 30days
Locations
40 sites in 1 country. Site status is shown where the registry gives one.
Site not named
Birmingham, Alabama
Site not named
Phoenix, Arizona
Site not named
Jonesboro, Arkansas
Site not named
La Mesa, California
Site not named
San Diego, California
Site not named
Colorado Springs, Colorado
Site not named
Denver, Colorado
Site not named
Groton, Connecticut
Site not named
Clearwater, Florida
Site not named
Leesburg, Florida
Site not named
Miami, Florida
Site not named
North Miami, Florida
Site not named
Plantation, Florida
Site not named
Wellington, Florida
Site not named
Atlanta, Georgia
Site not named
Columbus, Georgia
Site not named
Roswell, Georgia
Site not named
Shawnee Mission, Kansas
Site not named
Baltimore, Maryland
Site not named
Fall River, Massachusetts
Site not named
Grand Rapids, Michigan
Site not named
Kalamazoo, Michigan
Site not named
Saginaw, Michigan
Site not named
Plainsboro, New Jersey
Site not named
New Bern, North Carolina
Site not named
Winston-Salem, North Carolina
Site not named
Columbus, Ohio
Site not named
Columbus, Ohio
Site not named
Philadelphia, Pennsylvania
Site not named
Philadelphia, Pennsylvania
Site not named
Myrtle Beach, South Carolina
Site not named
Jackson, Tennessee
Site not named
Corpus Christi, Texas
Site not named
Dallas, Texas
Site not named
Houston, Texas
Site not named
San Antonio, Texas
Site not named
Norfolk, Virginia
Site not named
Virginia Beach, Virginia
Site not named
Seattle, Washington
Site not named
Seattle, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.